|
|
| GeneID |
1817
|
| Symbol |
DRD5P1
|
| Synonyms |
-
|
| Description |
dopamine receptor D5 pseudogene 1 |
| See related |
HGNC:3027| |
| Locus tag |
- |
| Gene type |
pseudo |
| Map location |
2p11.2-p11.1 |
|
| |
|
|
| Gene set name |
Method of gene set |
Evidence |
Info |
| Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: [schizophrenias, schizophrenia] | Click to show detail |
|
| |
| General Gene Expression (microarray) ? |
|
 |
| |
| Gene Expression in Brain Regions (new) |
|
| |
| Top co-expressed genes in Brain Regions (new) |
|
| Gene | Pearson's Correlation | Spearman's Correlation | | |
| Top 10 positively co-expressed genes |
| GPC6 | 0.88 | 0.84 | | |
| CHEK1 | 0.84 | 0.84 | | |
| CDC25A | 0.83 | 0.76 | | |
| GINS1 | 0.83 | 0.81 | | |
| CCDC15 | 0.82 | 0.75 | | |
| DHX40 | 0.82 | 0.82 | | |
| C6orf167 | 0.82 | 0.75 | | |
| STON1-GTF2A1L | 0.82 | 0.75 | | |
| WDHD1 | 0.82 | 0.85 | | |
| STON1 | 0.82 | 0.76 | | |
Top 10 negatively co-expressed genes | | HLA-F | -0.52 | -0.71 | | |
| C5orf53 | -0.51 | -0.69 | | |
| AF347015.31 | -0.50 | -0.79 | | |
| AF347015.27 | -0.50 | -0.78 | | |
| AF347015.33 | -0.50 | -0.78 | | |
| FBXO2 | -0.50 | -0.60 | | |
| MT-CO2 | -0.50 | -0.80 | | |
| ALDOC | -0.49 | -0.67 | | |
| FXYD1 | -0.49 | -0.79 | | |
| MT-CYB | -0.49 | -0.77 | | |
|
| Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0004872 | receptor activity | IEA | | - |
| Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0007186 | G-protein coupled receptor protein signaling pathway | IEA | | - |
| Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
|---|
| GO:0016021 | integral to membrane | IEA | | - |
| |
